House approves cap on insulin costs, plan returns to Senate

Regional News

SPRINGFIELD, Ill. (AP) — The Illinois House has approved legislation to cap the amount diabetes patients must pay for insulin to $100 a month.

The vote Wednesday to answer skyrocketing prescription insulin costs was 100-13. The Senate has approved the idea but a change in the House requires another Senate vote.

Democratic Rep. Will Guzzardi of Chicago says his measure caps monthly out-of-pocket costs. It applies to state-regulated commercial insurance companies. Federally regulated insurance plans are not covered.

Insulin is necessary for people with diabetes to regulate blood sugar levels. About 1.3 million Illinois residents have diabetes, although not all rely on insulin.

Gov. J.B. Pritzker’s supports the plan. His office cites data indicating that insulin brands that sold for $40 in 2001 now sell for $289.

Skyrocketing prescription drug prices are an enormous burden for too many Illinois families, and this legislation will significantly lower out-of-pocket costs for the 1.3 million Illinoisans that rely on insulin. It’s fitting that on World Diabetes Day, Illinois has taken bold action to protect our residents’ health, rather than force them to use lower quality medication or even ration their supply. We are proud that Illinois continues to be a national leader in ensuring health care is a right and not a privilege. This important step forward for lowering health care costs is the result of the tireless advocacy of Sen. Andy Manar, Rep. Will Guzzardi and so many other champions. I look forward to signing this legislation and continuing my commitment to ensuring Illinois residents have access to comprehensive, high-quality and affordable health care coverage.”

Gov. JB Pritzker

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss

More Don't Miss

Trending Stories